I would like to model CAR-T cell therapy using an entirely mouse system, that is, a syngeneic model whereby mouse (ideally C57/Bl6) T-cells can be transduced with an anti mouse CD19 CAR and transferred to mice bearing a CD19+ leukaemia cell line.
Do such reagents exist?